| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/12/2006 | CN1263751C Novel compounds |
| 07/12/2006 | CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/12/2006 | CN1263743C Therapeutic morpholino-substituted compounds |
| 07/12/2006 | CN1263739C Carboxypeptidase U suppressed compound and its preparation method, pharmaceutical composition containing the compound and its uses |
| 07/12/2006 | CN1263736C Solution of tetrahydrate N-[ortho-(para-trimethyl acetoxyl benzenesulfonamide) benzoyl] glycine monosodium salt and its medicine |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/12/2006 | CN1263512C Concomitant drugs for treating glaucoma |
| 07/12/2006 | CN1263461C Cell growth regulating factor F and its preparation process |
| 07/12/2006 | CN1263460C Cell growth regulating factor G and its preparation process |
| 07/12/2006 | CN1263459C Cell growth regulating factor O and its preparation process |
| 07/12/2006 | CN1263447C Stable solution of reduced coenzyme Q |
| 07/11/2006 | US7074939 Indole derivatives as anti-inflammatory agents |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074905 An empty sc-MHC class II molecule comprising a peptide binding groove and a class II beta 2 chain comprising at least one amino acid substitution or deletion; immunosuppressants |
| 07/11/2006 | US7074901 Nucleotide sequences coding polypeptides for use in the tumor/cancer therapy |
| 07/11/2006 | US7074817 For treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis |
| 07/11/2006 | US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide |
| 07/11/2006 | US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 07/11/2006 | US7074807 Compositions and methods for inducing cell death |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 07/11/2006 | US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 07/11/2006 | US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074789 Kinase inhibitors |
| 07/11/2006 | US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074756 Liver generation promoter |
| 07/11/2006 | US7074614 Clock gene BMAL2 |
| 07/11/2006 | US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof |
| 07/11/2006 | US7074431 Expanding the homogeneous solution by exposing it to a change in pressure under conditions such that the solution or homogeneous dispersion does not boil |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074405 antibody binds target tissue and conjugate carrying epitope (haptens) |
| 07/11/2006 | US7074402 Treating different types of neuronal dysfunction, including stroke, Alzheimer's disease, Parkinson's disease, Huntington disease, neuroimmunological disorders such as multiple scelrosis |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/11/2006 | CA2298704C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 07/11/2006 | CA2294670C Composition suitable as food integrator and for the treatment of intestinal disorders and alterations of the bacterial flora |
| 07/11/2006 | CA2285548C Nicotinamide derivatives |
| 07/11/2006 | CA2269810C N-substituted 2-cyanopyrrolidines |
| 07/11/2006 | CA2238065C Medicament for circadian rhythm sleep disorder |
| 07/11/2006 | CA2163244C Quinoline derivatives as leukotriene antagonists |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/11/2006 | CA2126354C Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
| 07/06/2006 | WO2006070943A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | WO2006070934A1 Crystal of bicyclic fused heterocyclic derivative, process for production thereof, and use thereof |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070921A1 Type iv/type vii collagen production accelerator |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070873A1 Adiponectin inducer or secretagogue |
| 07/06/2006 | WO2006070856A1 Sesamin/episesamin compositions |
| 07/06/2006 | WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound |
| 07/06/2006 | WO2006070804A1 Method of inhibiting telomerase activity and inhibitor |
| 07/06/2006 | WO2006070726A1 N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same |
| 07/06/2006 | WO2006070618A1 Catecholamine regulator and foods, drinks, food additives and drugs containing the same |
| 07/06/2006 | WO2006050314A3 Once a day formulation for phosphate binders |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060149033 IGF antagonist peptides |
| 07/06/2006 | US20060148901 Acylated 4-amidino-and-4-guanidinobenzylamines for inhibition of plasma kallikrein |
| 07/06/2006 | US20060148885 Medicinal composition |
| 07/06/2006 | US20060148852 Visual function disorder improving agents |
| 07/06/2006 | US20060148849 Quinoline derivatives, process of synthesis and medicaments containing these derivatives |
| 07/06/2006 | US20060148844 Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
| 07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148761 Lipids |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148738 Preventive for adhesion following abdominal surgery |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060148728 Novel podophyllotoxin compositions |
| 07/06/2006 | US20060148723 Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient |
| 07/06/2006 | US20060148720 Use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148691 Sustained release preparation for therapy of coronary stenosis or obstruction |
| 07/06/2006 | US20060148675 Methods of reducing angiogenesis |
| 07/06/2006 | US20060148018 Insulin-like growth factor binding protein-4 protease |
| 07/06/2006 | US20060147920 Method of judging inflammatory disease |
| 07/06/2006 | US20060147565 Purified amylase inhibitor and novel process for obtaining the same |
| 07/06/2006 | US20060147558 Remedies |
| 07/06/2006 | US20060147551 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147397 Composition for preparation for external use on skin and method of using the same |
| 07/06/2006 | US20060147392 Agent for dissolving dental calculi and dental caries |
| 07/06/2006 | US20060147384 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 07/06/2006 | DE112004001603T5 TGF-β-Genexpressionsinhibitor TGF-β gene expression inhibitor |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2592532A1 Sesamin/episesamin compositions with improved bioavailability |